Through
4/26
Commentary by two Penn researchers outline a systematic framework for repurposing existing drugs to quickly find new therapies, after an observational study suggested statins may be helpful in combating COVID-19.
When physicians-in-training at the Perelman School of Medicine were sent home for remote work and virtual learning due to the pandemic, 80 fourth-year students immersed themselves in a crash course on COVID-19 virology, epidemiology, therapies, vaccines, and related topics.
The coronavirus crisis and the move to online events presented Penn’s Middle East Center with a rare opportunity to foster the first public conversation about the virus between senior health officials in Iran and counterparts in the United States.
A variety of research efforts across Penn are working to uncover the neurological implications of COVID-19, including stroke, neuroinflammation, and loss of smell.
Richard Prisinzano of the Penn Wharton Budget Model discusses the competing bills being debated in Congress while extended unemployment benefits stand in limbo.
The Translational Research Internship Program, offered by the Perelman School of Medicine’s Institute for Translational Medicine and Therapeutics Education Programs, provides mentorship for undergraduates as they complete a translational research project.
Current and former Wharton students created a free job-hunting website for the millions of Americans who have been laid off because of the coronavirus.
Partisanship, not health concerns, is the main driver of whether Americans are social distancing during the coronavirus pandemic, according to a new study.
Researchers from the Penn Institute of Immunology discovered three distinct immune responses to the SARS-CoV2 infection that could help predict the trajectory of disease in severe COVID-19 patients and may ultimately inform how to best treat them.
A new study from Penn Vet's New Bolton Center tests the guano of North American bats currently in Pennsylvania wildlife rehabilitation centers for the presence of COVID-19.
Nobel laureates Katalin Karikó and Drew Weissman of the Perelman School of Medicine appear on “Sunday Morning” to discuss their careers, their mRNA research, and the COVID-19 vaccines.
FULL STORY →
A paper co-authored by Penn researchers found that COVID-19 deaths in the U.S. were likely undercounted in official statistics during the first 30 months of the pandemic.
FULL STORY →
Katalin Karikó and Drew Weissman of the Perelman School of Medicine are noted for receiving awards from the Franklin Institute and subsequently being honored with a Nobel Prize.
FULL STORY →
Drew Weissman of the Perelman School of Medicine, who won the Nobel Prize along with Katalin Karikó, discusses the backlash against vaccinations and whether to receive the latest COVID vaccine.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues finds that long COVID’s neurological symptoms, like brain fog, memory loss, and fatigue, may stem from serotonin reduction.
FULL STORY →
A study by Christoph Thaiss and Maayan Levy of the Perelman School of Medicine and colleagues suggests that serotonin could be a target for long COVID treatment.
FULL STORY →